 Victoria Pelak
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 10 | 2024 | 443 | 3.150 |
Why?
| | Vision Disorders | 13 | 2023 | 130 | 2.720 |
Why?
| | Neurodegenerative Diseases | 4 | 2022 | 93 | 1.990 |
Why?
| | Eye Movements | 3 | 2021 | 53 | 1.290 |
Why?
| | Atrophy | 6 | 2024 | 152 | 1.280 |
Why?
| | Cerebral Cortex | 6 | 2022 | 381 | 1.210 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2024 | 9 | 0.910 |
Why?
| | Eye Diseases | 2 | 2020 | 76 | 0.900 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 284 | 0.840 |
Why?
| | Lewy Body Disease | 2 | 2020 | 26 | 0.820 |
Why?
| | Dementia | 3 | 2023 | 187 | 0.800 |
Why?
| | Tremor | 2 | 2021 | 45 | 0.780 |
Why?
| | Nervous System Diseases | 2 | 2020 | 252 | 0.770 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 1 | 2021 | 9 | 0.760 |
Why?
| | Ocular Motility Disorders | 4 | 2018 | 25 | 0.760 |
Why?
| | Fragile X Syndrome | 1 | 2021 | 64 | 0.750 |
Why?
| | Visual Perception | 2 | 2022 | 139 | 0.750 |
Why?
| | Macular Degeneration | 1 | 2022 | 152 | 0.700 |
Why?
| | Reading | 1 | 2021 | 149 | 0.700 |
Why?
| | Mucolipidoses | 1 | 2019 | 7 | 0.670 |
Why?
| | Tomography, Optical Coherence | 4 | 2022 | 130 | 0.670 |
Why?
| | Visual Pathways | 3 | 2018 | 44 | 0.650 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 340 | 0.620 |
Why?
| | Coronavirus Infections | 2 | 2020 | 332 | 0.620 |
Why?
| | Betacoronavirus | 2 | 2020 | 252 | 0.610 |
Why?
| | Neurology | 1 | 2018 | 84 | 0.570 |
Why?
| | Visual Fields | 5 | 2022 | 77 | 0.570 |
Why?
| | Ophthalmology | 1 | 2018 | 77 | 0.570 |
Why?
| | Migraine Disorders | 1 | 2018 | 82 | 0.570 |
Why?
| | Androgens | 1 | 2016 | 167 | 0.490 |
Why?
| | Aging | 3 | 2023 | 1620 | 0.480 |
Why?
| | Magnetic Resonance Imaging | 10 | 2024 | 3039 | 0.480 |
Why?
| | Visual Acuity | 7 | 2023 | 274 | 0.460 |
Why?
| | Optic Neuropathy, Ischemic | 3 | 2012 | 30 | 0.450 |
Why?
| | Pandemics | 2 | 2020 | 1319 | 0.430 |
Why?
| | Testosterone | 1 | 2016 | 343 | 0.430 |
Why?
| | Humans | 48 | 2024 | 114757 | 0.420 |
Why?
| | Cognition | 2 | 2023 | 989 | 0.360 |
Why?
| | Inflammation | 1 | 2020 | 2481 | 0.350 |
Why?
| | Optic Nerve Diseases | 2 | 2009 | 31 | 0.340 |
Why?
| | Optic Neuritis | 3 | 2020 | 37 | 0.340 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 2 | 2020 | 44 | 0.330 |
Why?
| | Vision, Low | 1 | 2009 | 14 | 0.330 |
Why?
| | Optic Nerve | 1 | 2009 | 65 | 0.320 |
Why?
| | Giant Cell Arteritis | 3 | 2020 | 48 | 0.290 |
Why?
| | Brain Diseases | 2 | 2017 | 124 | 0.290 |
Why?
| | Congresses as Topic | 2 | 2019 | 196 | 0.280 |
Why?
| | Male | 24 | 2024 | 55579 | 0.260 |
Why?
| | Cataract Extraction | 1 | 2006 | 76 | 0.250 |
Why?
| | Aged | 12 | 2023 | 19094 | 0.250 |
Why?
| | Nerve Net | 2 | 2022 | 226 | 0.240 |
Why?
| | Pseudotumor Cerebri | 2 | 2016 | 22 | 0.230 |
Why?
| | Middle Aged | 18 | 2024 | 26757 | 0.230 |
Why?
| | Cognition Disorders | 2 | 2023 | 477 | 0.230 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 96 | 0.220 |
Why?
| | Cognitive Aging | 1 | 2023 | 14 | 0.210 |
Why?
| | Immunosuppressive Agents | 4 | 2020 | 647 | 0.210 |
Why?
| | Female | 23 | 2024 | 59507 | 0.210 |
Why?
| | Lewy Bodies | 1 | 2022 | 7 | 0.200 |
Why?
| | Neuropsychological Tests | 3 | 2022 | 926 | 0.200 |
Why?
| | Unconsciousness | 1 | 2022 | 19 | 0.200 |
Why?
| | Phacoemulsification | 1 | 2023 | 107 | 0.200 |
Why?
| | White Matter | 1 | 2023 | 104 | 0.200 |
Why?
| | Ataxia | 1 | 2021 | 35 | 0.200 |
Why?
| | Amnesia | 2 | 2012 | 43 | 0.190 |
Why?
| | Diffusion Tensor Imaging | 2 | 2023 | 62 | 0.190 |
Why?
| | Retrospective Studies | 8 | 2024 | 12515 | 0.190 |
Why?
| | Retinal Ganglion Cells | 1 | 2022 | 92 | 0.190 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2021 | 51 | 0.190 |
Why?
| | Trochlear Nerve Diseases | 1 | 2001 | 6 | 0.190 |
Why?
| | Oculomotor Nerve Diseases | 1 | 2001 | 9 | 0.190 |
Why?
| | Abducens Nerve Diseases | 1 | 2001 | 10 | 0.190 |
Why?
| | Cataract | 1 | 2023 | 185 | 0.190 |
Why?
| | Stents | 2 | 2016 | 475 | 0.180 |
Why?
| | Brain | 6 | 2023 | 2374 | 0.180 |
Why?
| | Myasthenia Gravis | 1 | 2020 | 18 | 0.180 |
Why?
| | Siderosis | 1 | 1999 | 2 | 0.170 |
Why?
| | Autonomic Fibers, Preganglionic | 1 | 1999 | 4 | 0.170 |
Why?
| | Pupil | 1 | 1999 | 13 | 0.170 |
Why?
| | Immunomodulation | 1 | 2020 | 84 | 0.170 |
Why?
| | Eye Movement Measurements | 1 | 2019 | 10 | 0.170 |
Why?
| | West Nile Fever | 1 | 2020 | 50 | 0.170 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 140 | 0.170 |
Why?
| | Hearing Loss | 1 | 2023 | 184 | 0.170 |
Why?
| | Brain Stem | 1 | 2000 | 101 | 0.170 |
Why?
| | Steroids | 1 | 2020 | 145 | 0.170 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2019 | 36 | 0.170 |
Why?
| | Frontotemporal Dementia | 1 | 2019 | 22 | 0.160 |
Why?
| | Postoperative Complications | 2 | 2023 | 2127 | 0.160 |
Why?
| | Immune System | 1 | 2020 | 173 | 0.160 |
Why?
| | Facial Recognition | 1 | 2019 | 25 | 0.160 |
Why?
| | San Francisco | 1 | 2018 | 54 | 0.160 |
Why?
| | Facial Expression | 1 | 2019 | 60 | 0.160 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2018 | 43 | 0.150 |
Why?
| | Vestibule, Labyrinth | 1 | 2018 | 54 | 0.150 |
Why?
| | Critical Care | 1 | 2021 | 473 | 0.140 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 20 | 0.140 |
Why?
| | Transverse Sinuses | 1 | 2016 | 8 | 0.140 |
Why?
| | Adult | 13 | 2022 | 30548 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2021 | 3005 | 0.130 |
Why?
| | Immunotherapy | 1 | 2020 | 475 | 0.130 |
Why?
| | Universities | 1 | 2018 | 339 | 0.130 |
Why?
| | Papilledema | 2 | 2018 | 40 | 0.130 |
Why?
| | Laser Therapy | 1 | 2017 | 100 | 0.130 |
Why?
| | Amygdala | 1 | 2017 | 170 | 0.130 |
Why?
| | Brain Mapping | 3 | 2022 | 524 | 0.120 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 935 | 0.120 |
Why?
| | Biomarkers | 2 | 2024 | 3416 | 0.110 |
Why?
| | Parkinson Disease | 1 | 2018 | 345 | 0.110 |
Why?
| | Biomedical Research | 1 | 2019 | 585 | 0.110 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2023 | 83 | 0.110 |
Why?
| | Multiple Sclerosis | 3 | 2020 | 380 | 0.110 |
Why?
| | Hippocampus | 1 | 2017 | 695 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1350 | 0.100 |
Why?
| | Optic Disk Drusen | 1 | 2012 | 5 | 0.100 |
Why?
| | Visual Field Tests | 1 | 2011 | 13 | 0.100 |
Why?
| | Cranial Sinuses | 1 | 2011 | 12 | 0.100 |
Why?
| | Optic Disk | 2 | 2009 | 38 | 0.100 |
Why?
| | Hemodynamics | 1 | 2016 | 1013 | 0.100 |
Why?
| | Hemianopsia | 1 | 2011 | 9 | 0.100 |
Why?
| | Memory, Episodic | 1 | 2012 | 38 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2358 | 0.090 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1340 | 0.090 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 152 | 0.090 |
Why?
| | Nervous System Malformations | 1 | 2009 | 34 | 0.080 |
Why?
| | Hypokinesia | 1 | 2008 | 7 | 0.080 |
Why?
| | Stiff-Person Syndrome | 1 | 2008 | 7 | 0.080 |
Why?
| | Age of Onset | 2 | 2020 | 448 | 0.070 |
Why?
| | Rest | 2 | 2022 | 103 | 0.070 |
Why?
| | Arteritis | 1 | 2006 | 27 | 0.070 |
Why?
| | Spinal Nerve Roots | 1 | 2005 | 28 | 0.060 |
Why?
| | Cranial Nerve Diseases | 1 | 2005 | 42 | 0.060 |
Why?
| | Animals | 4 | 2023 | 31762 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1796 | 0.060 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2005 | 121 | 0.060 |
Why?
| | Blindness, Cortical | 1 | 2003 | 5 | 0.060 |
Why?
| | Adolescent | 6 | 2020 | 17808 | 0.060 |
Why?
| | Gliosis | 1 | 2023 | 29 | 0.050 |
Why?
| | Neurites | 1 | 2023 | 43 | 0.050 |
Why?
| | Demography | 1 | 2024 | 262 | 0.050 |
Why?
| | Young Adult | 4 | 2022 | 10463 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4420 | 0.050 |
Why?
| | Pulvinar | 1 | 2022 | 4 | 0.050 |
Why?
| | Amyloid beta-Peptides | 1 | 2024 | 189 | 0.050 |
Why?
| | Pre-Eclampsia | 1 | 2003 | 165 | 0.050 |
Why?
| | Diplopia | 1 | 2001 | 16 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 249 | 0.050 |
Why?
| | Functional Laterality | 1 | 2022 | 198 | 0.050 |
Why?
| | Connectome | 1 | 2022 | 63 | 0.050 |
Why?
| | Strabismus | 1 | 2001 | 26 | 0.050 |
Why?
| | Treatment Failure | 2 | 2016 | 332 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 4901 | 0.050 |
Why?
| | Vision Tests | 1 | 2000 | 15 | 0.040 |
Why?
| | Vision, Ocular | 1 | 2000 | 30 | 0.040 |
Why?
| | Immunization, Passive | 1 | 2020 | 73 | 0.040 |
Why?
| | Temporal Lobe | 2 | 2012 | 79 | 0.040 |
Why?
| | Demyelinating Diseases | 1 | 2020 | 75 | 0.040 |
Why?
| | New Orleans | 1 | 2019 | 14 | 0.040 |
Why?
| | Eye Pain | 1 | 2018 | 7 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2018 | 49 | 0.040 |
Why?
| | Encephalitis | 1 | 2020 | 127 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2023 | 9089 | 0.040 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 255 | 0.040 |
Why?
| | Recurrence | 1 | 2020 | 936 | 0.040 |
Why?
| | Focus Groups | 1 | 2018 | 385 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 594 | 0.030 |
Why?
| | Transfection | 1 | 2018 | 870 | 0.030 |
Why?
| | Child, Preschool | 2 | 2020 | 9079 | 0.030 |
Why?
| | Hospital Mortality | 1 | 1999 | 776 | 0.030 |
Why?
| | Patient Participation | 1 | 2018 | 360 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1086 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2018 | 774 | 0.030 |
Why?
| | Emotions | 1 | 2019 | 472 | 0.030 |
Why?
| | Child | 3 | 2020 | 18352 | 0.030 |
Why?
| | Qualitative Research | 1 | 2018 | 935 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4086 | 0.030 |
Why?
| | Disease Management | 1 | 2016 | 560 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2023 | 6350 | 0.030 |
Why?
| | Color Vision Defects | 1 | 2012 | 6 | 0.030 |
Why?
| | Spinal Puncture | 1 | 2012 | 19 | 0.030 |
Why?
| | Phlebography | 1 | 2011 | 34 | 0.020 |
Why?
| | Cerebral Angiography | 1 | 2011 | 109 | 0.020 |
Why?
| | Stroke | 1 | 1999 | 1019 | 0.020 |
Why?
| | Lymphokines | 1 | 1991 | 111 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4625 | 0.020 |
Why?
| | Hospitalization | 1 | 1999 | 1752 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2812 | 0.020 |
Why?
| | Autoradiography | 1 | 1989 | 70 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1226 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 1991 | 384 | 0.020 |
Why?
| | Supranuclear Palsy, Progressive | 1 | 2008 | 7 | 0.020 |
Why?
| | Macaca mulatta | 1 | 1989 | 131 | 0.020 |
Why?
| | Saccades | 1 | 2008 | 35 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1989 | 116 | 0.020 |
Why?
| | Blindness | 1 | 2008 | 37 | 0.020 |
Why?
| | Oculomotor Muscles | 1 | 2008 | 40 | 0.020 |
Why?
| | Killer Cells, Natural | 1 | 1991 | 382 | 0.020 |
Why?
| | Withholding Treatment | 1 | 2008 | 68 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2008 | 160 | 0.020 |
Why?
| | Frontal Lobe | 1 | 1989 | 140 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2008 | 144 | 0.020 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2008 | 122 | 0.020 |
Why?
| | Pilot Projects | 1 | 2012 | 1370 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2008 | 140 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1991 | 618 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1691 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 1991 | 1044 | 0.020 |
Why?
| | Electromyography | 1 | 2008 | 326 | 0.020 |
Why?
| | Cranial Nerves | 1 | 2005 | 11 | 0.020 |
Why?
| | Sural Nerve | 1 | 2005 | 19 | 0.020 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2005 | 41 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 448 | 0.020 |
Why?
| | Graves Disease | 1 | 2005 | 32 | 0.020 |
Why?
| | Hypertrophy | 1 | 2005 | 109 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2011 | 2763 | 0.010 |
Why?
| | Mice | 1 | 2020 | 14916 | 0.010 |
Why?
| | Myelin Sheath | 1 | 2005 | 144 | 0.010 |
Why?
| | Axons | 1 | 2005 | 177 | 0.010 |
Why?
| | Disease Progression | 1 | 2008 | 2387 | 0.010 |
Why?
| | Contrast Sensitivity | 1 | 2000 | 12 | 0.010 |
Why?
| | Observer Variation | 1 | 2000 | 295 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2008 | 1472 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 742 | 0.010 |
Why?
| | Walking | 1 | 2000 | 422 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2269 | 0.010 |
Why?
| | Age Factors | 1 | 1999 | 2890 | 0.010 |
Why?
| | Pregnancy | 1 | 2003 | 5525 | 0.010 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 84 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1991 | 193 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 1991 | 80 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1991 | 67 | 0.010 |
Why?
| | CD3 Complex | 1 | 1991 | 92 | 0.010 |
Why?
| | Receptors, Fc | 1 | 1991 | 45 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1991 | 97 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 309 | 0.010 |
Why?
| | Base Sequence | 1 | 1991 | 2118 | 0.000 |
Why?
| | Molecular Sequence Data | 1 | 1991 | 2791 | 0.000 |
Why?
| | Gene Expression | 1 | 1991 | 1420 | 0.000 |
Why?
| | RNA | 1 | 1991 | 810 | 0.000 |
Why?
|
|
Pelak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|